Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 12 Aug 2026 for Bicara Therapeutics Inc., €41k. Read the official filing
Filing timeline
BuySaleIvan Hyep
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ivan Hyep: trading record in brief
Ivan Hyep discloses dealings in Bicara Therapeutics Inc. to SEC (Form 4). The record holds 17 filings, for trades running from 6 October 2025 to 10 August 2026.
The open-market record consists of 6 sales worth €1.4M, with no purchase. Outside the open market, there are 11 option exercises. 2026 to date brings no purchases and 6 sales.
Most recently, on 12 August 2026, the filings show an option exercise worth €41k in Bicara Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ivan Hyep
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
17 of 17 declarations
